2376-0249
Clinical-Medical Image - International Journal of Clinical & Medical Images (2024) Volume 11, Issue 11
Author(s): Alexandra Lutz*
Department of Neurophysiological, University of Strasbourg, Strasbourg, France
Received: 01 November, 2024, Manuscript No. ijcmi-24-156575; Editor assigned: 02 November, 2024, Pre QC No. P-156575; Reviewed: 18 November, 2024, QC No. Q-156575; Revised: 23 November, 2024, Manuscript No. R-156575; Published: 30 November, 2024, DOI: 10.4172/2376-0249.1000989
Citation: Lutz A. (2024) Sonographic Alterations of the Phrenic Nerve in ALS Patients: Correlation with Clinical and Neurophysiological Observations. Int J Clin Med Imaging 11: 989.
Copyright: © 2024 Lutz A. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Phrenic nerve sonography has emerged as a valuable tool for evaluating respiratory function in patients with amyotrophic lateral sclerosis, offering insights that complement clinical and neurophysiological assessments. ALS, a progressive neurodegenerative disease, affects motor neurons, including those responsible for diaphragmatic function, often leading to respiratory complications. Understanding the alterations in the phrenic nerve provides critical information on disease progression and respiratory involvement. Recent studies highlight significant sonographic changes in the phrenic nerve among ALS patients, characterized by reduced cross-sectional area and altered echogenicity. These findings correlate with clinical parameters such as disease duration, respiratory symptoms, and severity of motor impairment. Neurophysiological assessments, including nerve conduction studies and diaphragm electromyography, further validate these observations by demonstrating impaired phrenic nerve conduction and reduced diaphragmatic activity. Combining sonographic and neurophysiological data offers a more comprehensive evaluation of respiratory dysfunction in ALS.
The integration of phrenic nerve sonography into routine ALS management provides several benefits. It serves as a non-invasive, reproducible method to monitor disease progression, particularly in its impact on respiratory muscles. Additionally, sonography can detect early phrenic nerve involvement, even before overt respiratory symptoms appear, enabling timely interventions such as non-invasive ventilation. These insights underscore the potential of sonography to enhance diagnostic accuracy and improve patient care.
In conclusion, phrenic nerve sonography, in conjunction with clinical and neurophysiological findings, offers valuable information on respiratory involvement in ALS. Its ability to detect early alterations and monitor progression positions it as a critical tool in managing this complex disease. Further research is warranted to refine sonographic techniques and explore their prognostic value in larger, multicenter studies, paving the way for more personalized and effective management strategies for ALS patients [1,2].
Phrenic nerve; Respiratory dysfunction; Diaphragm electromyography
None.
None.
[1] Laucius O, Drūteika J, Balnytė R, Palačionytė J and Ališauskienė, M, et al (2024). Phrenic Nerve Sonography Alterations in Patients with ALS: Insight with Clinical and Neurophysiological Findings.J Clin Med 13(21) 6302.
Google Scholar, Crossref, Indexed at
[2] Pinto S, Alves P, Swash M and de Carvalho, M (2017). Phrenic nerve stimulation is more sensitive than ultrasound measurement of diaphragm thickness in assessing early ALS progression.NCCN 47(1) 69-73.